Technology and Methodology in Glaucoma Case Detection
Even the most powerful handheld screening tool for glaucoma will not find cases cost-effectively because the disease prevalence is low. However, a tier 1 biomarker tool that enhances disease prevalence followed by the use of a screening tool could serve as a future glaucoma screening strategy.
Authors
- Louis R. Pasquale (ORCID: https://orcid.org/0000-0002-5835-3496)
Institutions
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of Glaucoma
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1097/ijg.0000000000002424
- Primary Topic
- Retinal Imaging and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00